SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-003700
Filing Date
2018-05-09
Accepted
2018-05-09 08:01:48
Documents
46
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050918p.htm 10-Q 717037
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8631
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8555
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5955
  Complete submission text file 0001171843-18-003700.txt   2591312

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20180331.xml EX-101.INS 344079
6 XBRL SCHEMA FILE prto-20180331.xsd EX-101.SCH 31154
7 XBRL CALCULATION FILE prto-20180331_cal.xml EX-101.CAL 22196
8 XBRL DEFINITION FILE prto-20180331_def.xml EX-101.DEF 200800
9 XBRL LABEL FILE prto-20180331_lab.xml EX-101.LAB 184425
10 XBRL PRESENTATION FILE prto-20180331_pre.xml EX-101.PRE 216194
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 18816717
SIC: 2836 Biological Products, (No Diagnostic Substances)